Search results for "Agoni"

showing 10 items of 2493 documents

Multi-isotopic and trace element evidence against different formation pathways for oyster microstructures

2021

Geochimica et cosmochimica acta 308, 326-352 (2021). doi:10.1016/j.gca.2021.06.012

BiomineralizationRARE-EARTH-ELEMENTSOysternitrogen isotopes550010504 meteorology & atmospheric sciencesPaleoclimateXRF010502 geochemistry & geophysicsSulfur isotopes01 natural sciencesMineralization (biology)Clumped isotopesMg/Cachemistry.chemical_compoundSclerochronologyddc:550CALCIFICATION RATECRASSOSTREA-GIGASCalcitebiologyStable isotope ratioOysterDistribution coefficientBivalveCalcitetrace elementOxygen isotope ratio cyclePacific oysterSTABLE-ISOTOPEStable isotopeIsotopes of nitrogenChemistryNORTH-SEASEMMECHANICAL CHARACTERISTICSmicrostructureCrassostrea gigas [Portuguese oyster]Ostreidae [oysters]MineralogyGeochemistry and Petrologybiology.animalClumpcd isotopes0105 earth and related environmental sciencesTrace elementARAGONITIC BIVALVE SHELLSbiology.organism_classificationBivalviachemistryTEMPERATURE-DEPENDENCEFORAMINIFERAL CALCITECrassostrea gigasHIGH-RESOLUTION
researchProduct

Melatonin activates the peroxidase-oxidase reaction and promotes oscillations.

2001

We have studied the peroxidase-oxidase reaction with NADH and O2 as substrates and melatonin as a cofactor in a semibatch reactor. We show for the first time that melatonin is an activator of the reaction catalyzed by enzymes from both plant and animal sources. Furthermore, melatonin promotes oscillatory dynamics in the pH range from 5 to 6. The frequency of the oscillations depends on the pH such that an increase in pH was accompanied by a decrease in frequency. Conversely, an increase in the flow rate of NADH or an increase in the average concentration of NADH resulted in an increase in oscillation frequency. Complex dynamics were not observed with melatonin as a cofactor. These results a…

BiophysicsBiochemistryHorseradish peroxidaseCofactorCatalysisMelatoninOscillometrymedicineAnimalsLactoperoxidaseMolecular BiologyHorseradish PeroxidaseMelatoninchemistry.chemical_classificationOxidase testbiologyChemistryLactoperoxidaseCell BiologyHydrogen-Ion ConcentrationNADOxygenKineticsEnzymeMilkBiochemistryModels ChemicalPeroxidasesbiology.proteinCattleNAD+ kinaseSoybeansOxidoreductaseshormones hormone substitutes and hormone antagonistsPeroxidasemedicine.drugBiochemical and biophysical research communications
researchProduct

Arte, sapere e sussunzione biopolitica nell’età del capitalismo cognitivo

2011

La ricerca che in questa occasione assume la sua prima e parziale forma espositiva è indirizzata all’analisi del rapporto intercorrente tra l’attività definita “artistica” e il regime di accumulazione post-fordista. Con essa si propone dunque l’indagine del ruolo dei saperi e delle conoscenze, in particolare di quelli afferenti al campo artistico, nel processo di sussunzione biopolitica del lavoro alle leggi dell’accumulazione del capitale a partire dall’ipotesi del cosiddetto capitalismo cognitivo. Per appagare l’esigenza scientifica di definizione dell’oggetto indagato, all’interno di un quadro teorico e metodologico coerente, si cercherà in prima battuta di esporre la concezione material…

Biopolitica bioeconomia arte capitalismo cognitivo movimenti antagonisti
researchProduct

Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Bisoprolol Fumarate

2014

Abstract Literature data relevant to the decision to allow a waiver of in vivo bioequivalence (BE) testing for the approval of immediate-release (IR) solid oral dosage forms containing bisoprolol as the sole active pharmaceutical ingredient (API) are reviewed. Bisoprolol is classified as a Class I API according to the current Biopharmaceutics Classification System (BCS). In addition to the BCS class, its therapeutic index, pharmacokinetic properties, data related to the possibility of excipient interactions, and reported BE/bioavailability problems are taken into consideration. Qualitative compositions of IR tablet dosage forms of bisoprolol with a marketing authorization (MA) in ICH (Inter…

Bisoprolol FumarateCell Membrane PermeabilityAdrenergic beta-AntagonistsBiological AvailabilityPharmaceutical ScienceExcipientPharmacologyBioequivalenceDosage formBiopharmaceuticsExcipientsmedicineBisoprololHumansTissue DistributionBiotransformationChromatography High Pressure LiquidHeart FailureActive ingredientChemistryStereoisomerismHydrogen-Ion ConcentrationBiopharmaceutics Classification SystemBioavailabilityIntestinal AbsorptionSolubilityTherapeutic EquivalencyBisoprololmedicine.drugJournal of Pharmaceutical Sciences
researchProduct

Incretins, Pregnancy, and Gestational Diabetes

2015

The number of pregnant women affected by gestational diabetes mellitus (GDM) is increasing among Caucasians, and East Asians. GDM also increases the risk for later advent of type 2 diabetes mellitus (T2DM), obesity, and cardiovascular disease in both women and their offspring. The underlying mechanism of GDM is not fully elucidated. Incretins such as glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP), have been suggested to have a role in maternal metabolism and weight as well as fetal growth. These hormones might be implicated in mechanisms that compensate for the increment in glycemia and insulin resistance seen during pregnancy, while other factors, such a…

Blood Glucose0301 basic medicineendocrine systemmedicine.medical_specialtyendocrine system diseasesOffspringPharmaceutical ScienceIncretinGastric Inhibitory PolypeptideType 2 diabetes030204 cardiovascular system & hematologyIncretins03 medical and health sciences0302 clinical medicineInsulin resistanceGlucagon-Like Peptide 1PregnancyRisk FactorsInternal medicineGlucose IntoleranceAnimalsHumansMedicineObesityPregnancybusiness.industrynutritional and metabolic diseasesType 2 Diabetes MellitusType 2 diabetesIncretinmedicine.diseaseObesityGestational diabetesDiabetes Gestational030104 developmental biologyEndocrinologyGestational diabeteDiabetes Mellitus Type 2FemaleInsulin Resistancebusinesshormones hormone substitutes and hormone antagonistsBiotechnologyCurrent Pharmaceutical Biotechnology
researchProduct

GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanisms

2018

Type 2 diabetes mellitus (T2DM) is a metabolic condition with an elevated impact on cardiovascular (CV) risk. The innovative therapeutic approaches for T2DM - incretin-based therapies (IBTs), including glucagon-like peptide 1 (GLP-1) receptor agonists, have become popular and more widely used in recent years. The available scientific data from clinical studies and clinical practice highlights their beyond glucose-lowering effects, which is achieved without any increase in hypoglycaemia. The former effects include reduction in body weight, lipids, blood pressure, inflammatory markers, oxidative stress, endothelial dysfunction, and subclinical atherosclerosis, thus reducing and potentially pr…

Blood GlucoseCardiometabolic parameterGlucagon-Like PeptidesIncretin030209 endocrinology & metabolism030204 cardiovascular system & hematologyBioinformaticsIncretinsGlucagon-Like Peptide-1 Receptor03 medical and health sciences0302 clinical medicineDiabetes mellitusmedicineHumansHypoglycemic AgentsEndothelial dysfunctionMolecular BiologyGlucagon-like peptide 1 receptorLiraglutidebusiness.industryType 2 Diabetes MellitusLiraglutideCardiovascular riskmedicine.diseasePlaque AtheroscleroticType 2 diabetes mellituBlood pressureDiabetes Mellitus Type 2Cardiovascular DiseasesMetabolic control analysisGlucagon-like peptide 1 receptor agonistMolecular Medicinebusinessmedicine.drugBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
researchProduct

Incretin Response to Mixed Meal Challenge in Active Cushing’s Disease and after Pasireotide Therapy

2022

Cushing’s disease (CD) causes diabetes mellitus (DM) through different mechanisms in a significant proportion of patients. Glucose metabolism has rarely been assessed with appropriate testing in CD; we aimed to evaluate hormonal response to a mixed meal tolerance test (MMTT) in CD patients and analyzed the effect of pasireotide (PAS) on glucose homeostasis. To assess gastro-entero-pancreatic hormones response in diabetic (DM+) and non-diabetic (DM–) patients, 26 patients with CD underwent an MMTT. Ten patients were submitted to a second MMTT after two months of PAS 600 µg twice daily. The DM+ group had significantly higher BMI, waist circumference, glycemia, HbA1c, ACTH le…

Blood GlucoseCushing’s disease; diabetes mellitus; incretin; mixed meal test tolerance test; pasireotidemixed meal test tolerance testGastric Inhibitory PolypeptideIncretinsCatalysisInorganic ChemistryGlucagon-Like Peptide 1HumansInsulinPhysical and Theoretical ChemistryPituitary ACTH HypersecretionMolecular BiologyMealsSpectroscopyGlycated HemoglobinpasireotideC-Peptidediabetes mellituOrganic Chemistrydigestive oral and skin physiologyGeneral MedicineCushing’s diseaseGlucagonincretinComputer Science ApplicationsDiabetes Mellitus Type 2Cushing’s disease; mixed meal test tolerance test; diabetes mellitus; incretin; pasireotidediabetes mellituspasireotide.Insulin ResistanceSomatostatinhormones hormone substitutes and hormone antagonists
researchProduct

Physiological and agonistic behavioural response of Procambarus clarkii to an acoustic stimulus

2012

Summary This study examined the effects of an acoustic stimulus on the haemolymph and agonistic behaviour of the red swamp crayfish Procambarus clarkii. The experiment was conducted in a tank equipped with a video recording system using 6 groups (3 control and 3 test groups) of five adult crayfish (30 specimens in total). After one hour of habituation, the behaviour of the crayfish was monitored for two hours. During the second hour, the animals in the test groups were exposed to a linear sweep (frequency range 0.1-25 kHz; peak amplitude 148 dBrms re 1 µPa at 12 kHz) acoustic stimulus for 30 minutes. Exposure to the noise produced significant variations in haemato-immunological parameters a…

Blood GlucoseFish ProteinsMaleHemocytesSound SpectrographyPhysiologyVideo RecordingCell CountAstacoideaAquatic ScienceStimulus (physiology)Animal scienceHemolymphAgonistic behaviourAnimalsHSP70 Heat-Shock ProteinsHabituationMolecular BiologyEcology Evolution Behavior and SystematicsVideo recordingProcambarus clarkiibiologyHemagglutinationOsmolar ConcentrationAnatomyacoustic stress agonistic behaviour physiological response red swamp crayfish.biology.organism_classificationCrayfishAcoustic StimulationInsect ScienceFemaleAnimal Science and ZoologyRabbitsAgonistic BehaviorJournal of Experimental Biology
researchProduct

Differential expression of the corticosteroid receptors GR1, GR2 and MR in rainbow trout organs with slow release cortisol implants

2012

The present study describes the transcriptional levels of the corticosteroid receptors (CRs) GR1, GR2 and MR in the different organs of the rainbow trout (Oncorhynchus mykiss) in response to a slow release of cortisol, throughout a 10-day period. We show that after short term (1 day after cortisol implantation), when the plasma levels of cortisol emulate an acute stress, the GR2 and MR expression levels were upregulated in the brain and head kidney tissues. This result reflects the role of these organs as regulators of the stress response. In general, the rest of the organs, especially gills, intestine, liver, muscle and spleen, showed decreased transcriptional levels of GR1, GR2 and MR, al…

Blood GlucoseFish Proteinsendocrine systemmedicine.medical_specialtyHydrocortisoneTranscription GeneticPhysiologymedicine.drug_classSpleenBiologyHematocritCarbohydrate metabolismBiochemistryReceptors GlucocorticoidDownregulation and upregulationStress PhysiologicalInternal medicinemedicineAnimalsChronic stressLactic AcidReceptorMolecular BiologyDrug Implantsmedicine.diagnostic_testOxygen transportBrainHead KidneyUp-RegulationReceptors Mineralocorticoidmedicine.anatomical_structureEndocrinologyOrgan SpecificityOncorhynchus mykissCorticosteroidhormones hormone substitutes and hormone antagonistsComparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology
researchProduct

Glycometabolic control in Acromegalic patients with Diabetes: a study of the effects of different treatments for GH excess and for hyperglycaemia.

2012

Background. Diabetes mellitus (DM) is frequently observed in patients with acromegaly. Current therapies for acromegaly may impact glucose regulation, influencing insulin sensitivity and secretion. The question whether these therapies modify control and progression of diabetes once present is still open. Aim. Aim of our study is to analyse glucose control in acromegalic patients with diabetes, evaluating the relation with treatments for GH excess and for diabetes. Methods. Seventy patients with acromegaly and diabetes were studied. Duration and treatments of acromegaly and DM were recorded, together with clinical and metabolic parameters. Results. Most patients (92.8%) were treated with som…

Blood GlucoseGlycated HemoglobinHuman Growth HormoneEndocrine Surgical ProceduresAcromegaly diabetesMiddle AgedSettore MED/13 - EndocrinologiaCohort StudiesDiabetes ComplicationsdiabeteHyperglycemiadifferent treatmentsDopamine AgonistsDiabetes MellitusHumansacromegalySomatostatinAged
researchProduct